Combined activation of PPAR-gamma and PPAR-alpha reduces the negative effects of PPAR-gamma agonism on bone and may attenuate PPAR-gamma mediated loss of bone strength May 07, 2012 Tags: bone, preclinical, research In this episode, Rana Samadfam, Principal Scientist, Bone Biology at Charles River, provides a brief overview of one of the poster presentations to be held at the 2012 European Calcified Tissue Society Meeting. listen to podcast
